HEADER PENTAPEPTIDE REPEAT PROTEIN 09-MAR-05 2BM7 TITLE THE STRUCTURE OF MFPA (RV3361C, P3221 CRYSTAL FORM). THE PENTAPEPTIDE TITLE 2 REPEAT PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS FOLDS AS A RIGHT- TITLE 3 HANDED QUADRILATERAL BETA-HELIX. COMPND MOL_ID: 1; COMPND 2 MOLECULE: PENTAPEPTIDE REPEAT FAMILY PROTEIN; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: MFPA, RV3361C; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 83332; SOURCE 4 STRAIN: H37RV; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS PENTAPEPTIDE REPEAT PROTEIN, FLUROQUINOLONE RESISTANCE, DNA GYRASE, KEYWDS 2 DNA MIMICRY, RIGHT-HANDED QUADRILATERAL BETA-HELIX EXPDTA X-RAY DIFFRACTION AUTHOR S.S.HEGDE,M.W.VETTING,S.L.RODERICK,L.A.MITCHENALL,A.MAXWELL, AUTHOR 2 H.E.TAKIFF,J.S.BLANCHARD REVDAT 3 01-MAY-24 2BM7 1 REMARK REVDAT 2 24-FEB-09 2BM7 1 VERSN REVDAT 1 07-JUN-05 2BM7 0 JRNL AUTH S.S.HEGDE,M.W.VETTING,S.L.RODERICK,L.A.MITCHENALL,A.MAXWELL, JRNL AUTH 2 H.E.TAKIFF,J.S.BLANCHARD JRNL TITL A FLUROQUINOLONE RESISTANCE PROTEIN FROM MYCOBACTERIUM JRNL TITL 2 TUBERCULOSIS THAT MIMICS DNA JRNL REF SCIENCE V. 308 1480 2005 JRNL REFN ISSN 0036-8075 JRNL PMID 15933203 JRNL DOI 10.1126/SCIENCE.1110699 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.0 REMARK 3 NUMBER OF REFLECTIONS : 16076 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.289 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 784 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.82 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2760 REMARK 3 BIN FREE R VALUE : 0.3230 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4130 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 6 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 46.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.90200 REMARK 3 B22 (A**2) : -6.90200 REMARK 3 B33 (A**2) : 13.80400 REMARK 3 B12 (A**2) : -12.92300 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : SHELL MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 17.57 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: MISSING RESIDUES FROM THE N AND C- REMARK 3 TERMINI OF THE SUBMITTED COORDINATES AS COMPARED TO THE REMARK 3 SUBMITTED SEQUENCE ARE REGIONS WHICH EXHIBITED NO ELECTRON REMARK 3 DENSITY AND THEREFORE WERE NOT MODELED. REMARK 4 REMARK 4 2BM7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-MAR-05. REMARK 100 THE DEPOSITION ID IS D_1290023269. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 93.0 REMARK 200 PH : 4.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MSC RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16076 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.0 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.03000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.18000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PREVIOUS STRUCTURE DETERMINED BY SE-MET MAD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN (10MG/ML, 10% ETHYLENE GLYCOL, REMARK 280 200 MM AMMONIUM SULFATE) CRYSTALLIZED IN 30 % ETHYLENE GLYCOL, REMARK 280 100 MM CITRATE PHOSPHATE PH 4.0., PH 4.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 98.08133 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 49.04067 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 49.04067 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 98.08133 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICALLY ACTIVE MOLECULE IS DIMERIC REMARK 300 ANDTHE HEXAMERIC ASSEMBLY IS A TRIMER OF DIMERS. REMARK 300 A BIOLOGICALLY ACTIVE DIMERIC ARRANGEMENT ISALSO REMARK 300 OBSERVED IN A RELATED ENTRY 2BM4. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 145.63083 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 49.04067 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 GLN A 2 REMARK 465 GLY A 182 REMARK 465 GLY A 183 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 GLN B 2 REMARK 465 GLY C -2 REMARK 465 SER C -1 REMARK 465 HIS C 0 REMARK 465 MET C 1 REMARK 465 GLN C 2 REMARK 465 GLN C 3 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ALA A 181 CA C O CB REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU C 59 OG SER C 62 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 15 129.97 -31.38 REMARK 500 ASP A 16 15.70 55.76 REMARK 500 ASP A 86 75.95 60.86 REMARK 500 LEU A 91 16.86 53.66 REMARK 500 ASP A 116 19.92 56.12 REMARK 500 LYS A 121 -0.13 68.92 REMARK 500 ALA A 175 1.84 -65.69 REMARK 500 ASP B 6 36.88 33.26 REMARK 500 ARG B 15 131.69 -36.80 REMARK 500 LEU B 19 38.55 -98.94 REMARK 500 ARG B 21 19.25 47.03 REMARK 500 GLU B 41 15.75 45.03 REMARK 500 PHE B 54 76.30 -116.74 REMARK 500 LEU B 70 122.51 -39.50 REMARK 500 LEU B 91 13.79 52.42 REMARK 500 ASP B 141 18.06 58.87 REMARK 500 TRP B 154 11.35 -65.82 REMARK 500 ARG B 155 -12.54 -141.62 REMARK 500 ASP C 6 25.92 47.68 REMARK 500 ARG C 12 142.84 -37.97 REMARK 500 ARG C 15 129.44 -35.80 REMARK 500 SER C 20 153.72 -49.30 REMARK 500 ARG C 21 19.93 39.97 REMARK 500 ASN C 51 63.25 28.27 REMARK 500 LEU C 70 99.21 -43.25 REMARK 500 SER C 72 140.93 -35.78 REMARK 500 LEU C 91 -7.11 70.37 REMARK 500 GLU C 111 13.35 49.16 REMARK 500 ASP C 141 18.99 57.30 REMARK 500 ALA C 175 -2.29 -54.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2BM4 RELATED DB: PDB REMARK 900 THE STRUCTURE OF MFPA (RV3361C, C2 CRYSTAL FORM). THE PENTAPEPTIDE REMARK 900 REPEAT PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS FOLDS AS A RIGHT- REMARK 900 HANDED QUADRILATERAL BETA-HELIX. REMARK 900 RELATED ID: 2BM5 RELATED DB: PDB REMARK 900 THE STRUCTURE OF MFPA (RV3361C, C2 CRYSTAL FORM). THE PENTAPEPTIDE REMARK 900 REPEAT PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS FOLDS AS A RIGHT- REMARK 900 HANDED QUADRILATERAL BETA-HELIX. REMARK 900 RELATED ID: 2BM6 RELATED DB: PDB REMARK 900 THE STRUCTURE OF MFPA (RV3361C, C2 CRYSTAL FORM). THE PENTAPEPTIDE REMARK 900 REPEAT PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS FOLDS AS A RIGHT- REMARK 900 HANDED QUADRILATERAL BETA-HELIX. REMARK 999 REMARK 999 SEQUENCE REMARK 999 THREE RESIDUES FROM N-TERMINAL HIS-TAG REMAIN AFTER REMARK 999 THROMBIN CLEAVAGE OF THE TAG. DBREF 2BM7 A -2 0 PDB 2BM7 2BM7 -2 0 DBREF 2BM7 A 1 183 UNP O50390 O50390_MYCTU 1 183 DBREF 2BM7 B -2 0 PDB 2BM7 2BM7 -2 0 DBREF 2BM7 B 1 183 UNP O50390 O50390_MYCTU 1 183 DBREF 2BM7 C -2 0 PDB 2BM7 2BM7 -2 0 DBREF 2BM7 C 1 183 UNP O50390 O50390_MYCTU 1 183 SEQRES 1 A 186 GLY SER HIS MET GLN GLN TRP VAL ASP CYS GLU PHE THR SEQRES 2 A 186 GLY ARG ASP PHE ARG ASP GLU ASP LEU SER ARG LEU HIS SEQRES 3 A 186 THR GLU ARG ALA MET PHE SER GLU CYS ASP PHE SER GLY SEQRES 4 A 186 VAL ASN LEU ALA GLU SER GLN HIS ARG GLY SER ALA PHE SEQRES 5 A 186 ARG ASN CYS THR PHE GLU ARG THR THR LEU TRP HIS SER SEQRES 6 A 186 THR PHE ALA GLN CYS SER MET LEU GLY SER VAL PHE VAL SEQRES 7 A 186 ALA CYS ARG LEU ARG PRO LEU THR LEU ASP ASP VAL ASP SEQRES 8 A 186 PHE THR LEU ALA VAL LEU GLY GLY ASN ASP LEU ARG GLY SEQRES 9 A 186 LEU ASN LEU THR GLY CYS ARG LEU ARG GLU THR SER LEU SEQRES 10 A 186 VAL ASP THR ASP LEU ARG LYS CYS VAL LEU ARG GLY ALA SEQRES 11 A 186 ASP LEU SER GLY ALA ARG THR THR GLY ALA ARG LEU ASP SEQRES 12 A 186 ASP ALA ASP LEU ARG GLY ALA THR VAL ASP PRO VAL LEU SEQRES 13 A 186 TRP ARG THR ALA SER LEU VAL GLY ALA ARG VAL ASP VAL SEQRES 14 A 186 ASP GLN ALA VAL ALA PHE ALA ALA ALA HIS GLY LEU CYS SEQRES 15 A 186 LEU ALA GLY GLY SEQRES 1 B 186 GLY SER HIS MET GLN GLN TRP VAL ASP CYS GLU PHE THR SEQRES 2 B 186 GLY ARG ASP PHE ARG ASP GLU ASP LEU SER ARG LEU HIS SEQRES 3 B 186 THR GLU ARG ALA MET PHE SER GLU CYS ASP PHE SER GLY SEQRES 4 B 186 VAL ASN LEU ALA GLU SER GLN HIS ARG GLY SER ALA PHE SEQRES 5 B 186 ARG ASN CYS THR PHE GLU ARG THR THR LEU TRP HIS SER SEQRES 6 B 186 THR PHE ALA GLN CYS SER MET LEU GLY SER VAL PHE VAL SEQRES 7 B 186 ALA CYS ARG LEU ARG PRO LEU THR LEU ASP ASP VAL ASP SEQRES 8 B 186 PHE THR LEU ALA VAL LEU GLY GLY ASN ASP LEU ARG GLY SEQRES 9 B 186 LEU ASN LEU THR GLY CYS ARG LEU ARG GLU THR SER LEU SEQRES 10 B 186 VAL ASP THR ASP LEU ARG LYS CYS VAL LEU ARG GLY ALA SEQRES 11 B 186 ASP LEU SER GLY ALA ARG THR THR GLY ALA ARG LEU ASP SEQRES 12 B 186 ASP ALA ASP LEU ARG GLY ALA THR VAL ASP PRO VAL LEU SEQRES 13 B 186 TRP ARG THR ALA SER LEU VAL GLY ALA ARG VAL ASP VAL SEQRES 14 B 186 ASP GLN ALA VAL ALA PHE ALA ALA ALA HIS GLY LEU CYS SEQRES 15 B 186 LEU ALA GLY GLY SEQRES 1 C 186 GLY SER HIS MET GLN GLN TRP VAL ASP CYS GLU PHE THR SEQRES 2 C 186 GLY ARG ASP PHE ARG ASP GLU ASP LEU SER ARG LEU HIS SEQRES 3 C 186 THR GLU ARG ALA MET PHE SER GLU CYS ASP PHE SER GLY SEQRES 4 C 186 VAL ASN LEU ALA GLU SER GLN HIS ARG GLY SER ALA PHE SEQRES 5 C 186 ARG ASN CYS THR PHE GLU ARG THR THR LEU TRP HIS SER SEQRES 6 C 186 THR PHE ALA GLN CYS SER MET LEU GLY SER VAL PHE VAL SEQRES 7 C 186 ALA CYS ARG LEU ARG PRO LEU THR LEU ASP ASP VAL ASP SEQRES 8 C 186 PHE THR LEU ALA VAL LEU GLY GLY ASN ASP LEU ARG GLY SEQRES 9 C 186 LEU ASN LEU THR GLY CYS ARG LEU ARG GLU THR SER LEU SEQRES 10 C 186 VAL ASP THR ASP LEU ARG LYS CYS VAL LEU ARG GLY ALA SEQRES 11 C 186 ASP LEU SER GLY ALA ARG THR THR GLY ALA ARG LEU ASP SEQRES 12 C 186 ASP ALA ASP LEU ARG GLY ALA THR VAL ASP PRO VAL LEU SEQRES 13 C 186 TRP ARG THR ALA SER LEU VAL GLY ALA ARG VAL ASP VAL SEQRES 14 C 186 ASP GLN ALA VAL ALA PHE ALA ALA ALA HIS GLY LEU CYS SEQRES 15 C 186 LEU ALA GLY GLY FORMUL 4 HOH *6(H2 O) HELIX 1 1 ASP A 150 ARG A 155 1 6 HELIX 2 2 ASP A 165 ALA A 175 1 11 HELIX 3 3 VAL B 152 ALA B 157 1 6 HELIX 4 4 ASP B 165 ALA B 175 1 11 HELIX 5 5 ASP C 150 ALA C 157 1 8 HELIX 6 6 ASP C 165 ALA C 175 1 11 SHEET 1 AA 5 TRP A 4 VAL A 5 0 SHEET 2 AA 5 HIS A 23 GLU A 25 1 O HIS A 23 N TRP A 4 SHEET 3 AA 5 GLN A 43 ARG A 45 1 O GLN A 43 N THR A 24 SHEET 4 AA 5 THR A 63 SER A 68 1 O THR A 63 N HIS A 44 SHEET 5 AA 5 THR A 83 ASP A 88 1 O THR A 83 N PHE A 64 SHEET 1 AB 3 GLU A 8 THR A 10 0 SHEET 2 AB 3 MET A 28 SER A 30 1 O MET A 28 N PHE A 9 SHEET 3 AB 3 ALA A 48 ARG A 50 1 O ALA A 48 N PHE A 29 SHEET 1 AC 2 THR A 53 GLU A 55 0 SHEET 2 AC 2 VAL A 73 VAL A 75 1 O VAL A 73 N PHE A 54 SHEET 1 BA 5 TRP B 4 VAL B 5 0 SHEET 2 BA 5 HIS B 23 GLU B 25 1 O HIS B 23 N TRP B 4 SHEET 3 BA 5 GLN B 43 ARG B 45 1 O GLN B 43 N THR B 24 SHEET 4 BA 5 SER B 62 SER B 68 1 O THR B 63 N HIS B 44 SHEET 5 BA 5 LEU B 82 ASP B 88 1 O THR B 83 N PHE B 64 SHEET 1 BB 3 GLU B 8 THR B 10 0 SHEET 2 BB 3 MET B 28 SER B 30 1 O MET B 28 N PHE B 9 SHEET 3 BB 3 ALA B 48 ARG B 50 1 O ALA B 48 N PHE B 29 SHEET 1 BC 2 THR B 53 GLU B 55 0 SHEET 2 BC 2 VAL B 73 VAL B 75 1 O VAL B 73 N PHE B 54 SHEET 1 CA 3 GLU C 8 THR C 10 0 SHEET 2 CA 3 MET C 28 SER C 30 1 O MET C 28 N PHE C 9 SHEET 3 CA 3 ALA C 48 ARG C 50 1 O ALA C 48 N PHE C 29 SHEET 1 CB 4 HIS C 23 GLU C 25 0 SHEET 2 CB 4 GLN C 43 ARG C 45 1 O GLN C 43 N THR C 24 SHEET 3 CB 4 SER C 62 SER C 68 1 O THR C 63 N HIS C 44 SHEET 4 CB 4 LEU C 82 ASP C 88 1 O THR C 83 N PHE C 64 SHEET 1 CC 2 THR C 53 GLU C 55 0 SHEET 2 CC 2 VAL C 73 VAL C 75 1 O VAL C 73 N PHE C 54 CISPEP 1 ARG A 80 PRO A 81 0 0.38 CISPEP 2 ARG B 80 PRO B 81 0 -0.08 CISPEP 3 ARG C 80 PRO C 81 0 -0.51 CRYST1 84.080 84.080 147.122 90.00 90.00 120.00 P 32 2 1 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011893 0.006867 0.000000 0.00000 SCALE2 0.000000 0.013733 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006797 0.00000